MX9701394A - Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos. - Google Patents
Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos.Info
- Publication number
- MX9701394A MX9701394A MX9701394A MX9701394A MX9701394A MX 9701394 A MX9701394 A MX 9701394A MX 9701394 A MX9701394 A MX 9701394A MX 9701394 A MX9701394 A MX 9701394A MX 9701394 A MX9701394 A MX 9701394A
- Authority
- MX
- Mexico
- Prior art keywords
- delivery systems
- methods
- controlled release
- making same
- solid delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Detergent Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Developing Agents For Electrophotography (AREA)
- Lubricants (AREA)
Abstract
La presente invencion abarca sistemas de administracion de dosis solidas para la administracion de sustancias huéspedes. Los sistemas de administracion preferidos son convenientes para la administracion de materiales bioactivos a tejido subcutáneo e intradérmico, intramuscular, intravenoso, dando al sistema de administracion el tamaño y la forma para penetrar la epidermis. El sistema de administracion comprende un vehículo vítreo cargado con la sustancia huésped y capaz de liberar la sustancia huésped en el sitio a varias velocidades controladas. La presente invencion además incluye métodos para hacer y usar los sistemas de administracion de dosis solidas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9415810A GB9415810D0 (en) | 1994-08-04 | 1994-08-04 | Composition |
US08/349,029 US6290991B1 (en) | 1994-12-02 | 1994-12-02 | Solid dose delivery vehicle and methods of making same |
PCT/GB1995/001861 WO1996003978A1 (en) | 1994-08-04 | 1995-08-04 | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9701394A true MX9701394A (es) | 1998-03-31 |
Family
ID=26305403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9701394A MX9701394A (es) | 1994-08-04 | 1995-08-04 | Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos. |
Country Status (20)
Country | Link |
---|---|
EP (4) | EP1516615A3 (es) |
JP (2) | JPH10503769A (es) |
CN (1) | CN1152670C (es) |
AT (1) | ATE252373T1 (es) |
BG (1) | BG101278A (es) |
CA (1) | CA2197982C (es) |
CZ (1) | CZ297431B6 (es) |
DE (1) | DE69531992T2 (es) |
DK (1) | DK0773781T3 (es) |
EE (1) | EE03593B1 (es) |
ES (1) | ES2208687T3 (es) |
FI (1) | FI970867A (es) |
HU (1) | HUT77777A (es) |
MX (1) | MX9701394A (es) |
NO (1) | NO326966B1 (es) |
NZ (1) | NZ290896A (es) |
PL (1) | PL184068B1 (es) |
PT (1) | PT773781E (es) |
SK (1) | SK283026B6 (es) |
WO (1) | WO1996003978A1 (es) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
WO1996008979A1 (en) | 1994-09-22 | 1996-03-28 | Quadrant Holdings Cambridge Limited | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
GB9508691D0 (en) * | 1995-04-28 | 1995-06-14 | Pafra Ltd | Stable compositions |
GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
US6517860B1 (en) * | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
GB9705588D0 (en) | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
JP2002510316A (ja) * | 1997-07-03 | 2002-04-02 | クアドラント ホールディングス ケンブリッジ リミテッド | 修飾グリコシド、これを含む組成物およびその使用方法 |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
CA2317411C (en) * | 1998-01-30 | 2005-06-28 | Scios Inc. | Controlled release delivery of peptide or protein |
US6455096B1 (en) | 1998-04-28 | 2002-09-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Hard candy with a relatively-high moisture and hardness, and process of the same |
AU5751799A (en) * | 1998-09-09 | 2000-03-27 | Quadrant Holdings Cambridge Limited | Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them |
ATE244558T1 (de) | 1999-04-16 | 2003-07-15 | Novo Nordisk As | Trockene formbare arzneistoffformulierung |
GB9916316D0 (en) | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
PT1253932E (pt) * | 2000-02-08 | 2005-07-29 | Allergan Inc | Composicoes farmaceuticas de toxina botulinica |
US7780967B2 (en) | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US8632785B2 (en) | 2000-02-08 | 2014-01-21 | Allergan, Inc. | Clostridial toxin pharmaceutical composition containing a gelatin fragment |
JP3419729B2 (ja) * | 2000-03-16 | 2003-06-23 | 株式会社ファンケル | 錠剤およびその製造方法 |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
DK1280520T4 (en) | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
EP1452171B1 (en) * | 2000-10-13 | 2009-12-02 | Cambridge Biostability Limited | Pharmaceutical liquid suspensions |
RU2282468C2 (ru) | 2000-10-26 | 2006-08-27 | Алза Корпорейшн | Устройство для трансдермальной доставки лекарственных средств, имеющее микровыступы с покрытием |
MXPA03009603A (es) * | 2001-04-20 | 2004-12-06 | Johnson & Johnson | Arreglo de microproyeccion que tiene un agente benefico que contiene un recubrimiento. |
GB0124710D0 (en) * | 2001-10-15 | 2001-12-05 | Quadrant Healthcare Uk Ltd | Therapeutic composition |
ATE401058T1 (de) | 2001-11-01 | 2008-08-15 | Nektar Therapeutics | Sprühtrocknungsverfahren |
DE10157124A1 (de) * | 2001-11-21 | 2003-05-28 | Lohmann Therapie Syst Lts | Mikrofaserhaltige Vorrichtung zur kontrollierten Freisetzung von Stoffen |
US8454997B2 (en) | 2001-12-18 | 2013-06-04 | Novo Nordisk A/S | Solid dose micro implant |
EP1458360B1 (en) | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonary delivery of aminoglycosides |
ATE357219T1 (de) * | 2002-01-25 | 2007-04-15 | Glaxo Group Ltd | Darreichungsformen für dns |
GB0201736D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | DNA dosage forms |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
GB0210771D0 (en) * | 2002-05-10 | 2002-06-19 | Univ London Pharmacy | Derivatised particulate inhalation carriers |
EP1428526A1 (en) * | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
ES2437565T3 (es) | 2003-06-30 | 2014-01-13 | Alza Corporation | Formulaciones para microproyecciones revestidas que contienen contraiones no volátiles |
EP1643974A1 (en) * | 2003-07-11 | 2006-04-12 | Glaxo Group Limited | Inhalable pharmaceutical formulations comprising a sugar ester |
GB0327727D0 (en) * | 2003-11-28 | 2003-12-31 | Quadrant Drug Delivery Ltd | Viral microparticles |
ES2313350T3 (es) | 2004-05-12 | 2009-03-01 | Baxter International Inc. | Microesferas de acido nucleico, produccion y suministro de las mismas. |
DK1758558T3 (da) | 2004-05-12 | 2014-01-20 | Baxter Int | Oligonukleotidholdige mikrokugler samt deres anvendelse til fremstilling af et medikament til behandling af diabetes type 1 |
JP4547994B2 (ja) | 2004-06-02 | 2010-09-22 | 救急薬品工業株式会社 | 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤 |
TW200621310A (en) * | 2004-11-10 | 2006-07-01 | Univ Groningen | A process for preparing formulations of lypophilic active substances by spray freeze drying |
US20070009564A1 (en) | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
CA2624503A1 (en) | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
JP2009522288A (ja) | 2005-12-28 | 2009-06-11 | アルザ コーポレイション | 安定な治療剤形 |
EP1832281A1 (en) | 2006-03-10 | 2007-09-12 | Abbott GmbH & Co. KG | Process for producing a solid dispersion of an active ingredient |
US7887521B2 (en) | 2006-05-17 | 2011-02-15 | Alcon Research, Ltd. | Ophthalmic injection system |
US7871399B2 (en) | 2006-05-17 | 2011-01-18 | Alcon Research, Ltd. | Disposable ophthalmic injection device |
US20070270750A1 (en) | 2006-05-17 | 2007-11-22 | Alcon, Inc. | Drug delivery device |
US7674243B2 (en) | 2006-05-17 | 2010-03-09 | Alcon Inc. | Ophthalmic injection device using piezoelectric array |
US7811252B2 (en) | 2006-05-17 | 2010-10-12 | Alcon Research, Ltd. | Dosage control device |
US7862540B2 (en) | 2006-05-17 | 2011-01-04 | Alcon Research, Ltd. | Ophthalmic injection device using shape memory alloy |
US9022970B2 (en) | 2006-10-16 | 2015-05-05 | Alcon Research, Ltd. | Ophthalmic injection device including dosage control device |
US20080281292A1 (en) | 2006-10-16 | 2008-11-13 | Hickingbotham Dyson W | Retractable Injection Port |
PT2101731T (pt) * | 2006-11-21 | 2018-04-18 | Jina Pharmaceuticals Inc | Endoxifeno para utilização no tratamento de cancro |
GB2446780A (en) * | 2007-02-22 | 2008-08-27 | Glide Pharmaceutical Technolog | An elongate parenteral injection body having an injection point of angle 10 to 40 degrees. |
US7740619B2 (en) | 2007-08-01 | 2010-06-22 | Alcon Research, Ltd. | Spring driven ophthalmic injection device with safety actuator lockout feature |
US7629768B2 (en) | 2007-08-03 | 2009-12-08 | Alcon Research, Ltd. | Easy cleaning C-shaped charging base |
US8632511B2 (en) | 2009-05-06 | 2014-01-21 | Alcon Research, Ltd. | Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device |
GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
JP6062851B2 (ja) * | 2010-04-30 | 2017-01-18 | アロヴェイト・エルエルシー | 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット |
EP2397484A1 (en) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharide derivates, and their use as adjuvants |
CN104023743B (zh) | 2011-10-25 | 2017-05-03 | 普罗西纳治疗有限公司 | 抗体制剂和方法 |
KR101574760B1 (ko) | 2013-11-13 | 2015-12-04 | 주식회사 엘지생활건강 | 흡수속도를 개선한 마이크로니들 시스템 |
WO2015093452A1 (ja) | 2013-12-16 | 2015-06-25 | 武田薬品工業株式会社 | マイクロニードル |
US10182939B2 (en) | 2015-09-16 | 2019-01-22 | Novartis Ag | Hydraulic injector and methods for intra-ocular lens insertion |
MX2018002533A (es) | 2015-09-29 | 2018-06-27 | Kimberly Clark Co | Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora. |
KR102114993B1 (ko) * | 2015-10-15 | 2020-05-25 | 주식회사 파이안에스테틱스 | 폴리펩타이드 및/또는 세포 배양 여액을 함유하는 수용성 스크럽 입자를 포함하는 화장제 조성물 |
GB2545880A (en) | 2015-10-20 | 2017-07-05 | Glide Pharmaceutical Tech Ltd | Solid formulation |
BR112018017173A2 (pt) | 2016-02-23 | 2019-01-02 | Univ Colorado Regents | composições e métodos para a produção e uso de formulações imunogênicas termoestáveis com compatibilidade aumentada de uso como vacinas contra um ou mais patógenos |
IT201700101582A1 (it) * | 2017-09-12 | 2019-03-12 | Milano Politecnico | Dispositivo per rilascio intraoculare |
WO2023077447A1 (zh) * | 2021-11-05 | 2023-05-11 | 中国科学院过程工程研究所 | 环肽玻璃及含有环肽的药物组合物玻璃 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1080265B (de) * | 1958-09-30 | 1960-04-21 | Bayer Ag | Verfahren zur Herstellung von oral anzuwendenden Arzneimittel-zubereitungen mit protrahierter Wirkung aus Wirkstoffen und Schutzstoffen |
GB981372A (en) * | 1960-05-04 | 1965-01-27 | Pfizer Ltd | Pharmaceutical formulations for oral administration to animals |
DE3682047D1 (de) | 1985-07-09 | 1991-11-21 | Quadrant Bioresources Ltd | Beschuetzung von proteinen und aehnlichem. |
US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
JPH01288023A (ja) * | 1988-05-16 | 1989-11-20 | Nec Corp | ミリ波構内無線通信方式 |
GB8903593D0 (en) | 1989-02-16 | 1989-04-05 | Pafra Ltd | Storage of materials |
WO1990011756A1 (en) * | 1989-04-12 | 1990-10-18 | Aberdeen University | Slow release vitreous systems |
US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
GB9009390D0 (en) * | 1990-04-26 | 1990-06-20 | Smith Kline French Lab | Pharmaceutical compositions |
GB9010742D0 (en) * | 1990-05-14 | 1990-07-04 | Quadrant Bioresources Ltd | Stabilization of biological macromolecular substances |
DE69212497T2 (de) * | 1991-12-05 | 1996-12-12 | Mallinckrodt Veterinary Inc | Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe |
DK42093D0 (da) * | 1993-04-07 | 1993-04-07 | Bukh Meditec | Administrationsmetode |
TW360548B (en) * | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
-
1995
- 1995-08-04 EP EP04029125A patent/EP1516615A3/en not_active Withdrawn
- 1995-08-04 ES ES95927856T patent/ES2208687T3/es not_active Expired - Lifetime
- 1995-08-04 NZ NZ290896A patent/NZ290896A/xx not_active IP Right Cessation
- 1995-08-04 AT AT95927856T patent/ATE252373T1/de not_active IP Right Cessation
- 1995-08-04 HU HU9800694A patent/HUT77777A/hu unknown
- 1995-08-04 DE DE69531992T patent/DE69531992T2/de not_active Expired - Lifetime
- 1995-08-04 WO PCT/GB1995/001861 patent/WO1996003978A1/en active IP Right Grant
- 1995-08-04 EP EP95927856A patent/EP0773781B1/en not_active Revoked
- 1995-08-04 CN CNB951954962A patent/CN1152670C/zh not_active Expired - Fee Related
- 1995-08-04 SK SK277-97A patent/SK283026B6/sk unknown
- 1995-08-04 EP EP01116637A patent/EP1138319A3/en not_active Withdrawn
- 1995-08-04 DK DK95927856T patent/DK0773781T3/da active
- 1995-08-04 CZ CZ0047697A patent/CZ297431B6/cs not_active IP Right Cessation
- 1995-08-04 PT PT95927856T patent/PT773781E/pt unknown
- 1995-08-04 EE EE9700062A patent/EE03593B1/xx not_active IP Right Cessation
- 1995-08-04 MX MX9701394A patent/MX9701394A/es unknown
- 1995-08-04 EP EP01116638A patent/EP1138337A3/en not_active Withdrawn
- 1995-08-04 CA CA2197982A patent/CA2197982C/en not_active Expired - Fee Related
- 1995-08-04 JP JP8506345A patent/JPH10503769A/ja not_active Withdrawn
- 1995-08-04 PL PL95318898A patent/PL184068B1/pl not_active IP Right Cessation
-
1997
- 1997-02-28 FI FI970867A patent/FI970867A/fi active IP Right Revival
- 1997-02-28 BG BG101278A patent/BG101278A/xx unknown
- 1997-04-11 NO NO19971688A patent/NO326966B1/no not_active IP Right Cessation
-
2005
- 2005-09-29 JP JP2005284596A patent/JP2006056898A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9701394A (es) | Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos. | |
GEP20022707B (en) | Biodegrading Macromers for the Controlled Release of Biologically Active Substances | |
EP0301856A3 (en) | Delivery system | |
IL69431A (en) | Liquid delivery system particularly useful as an implantable micro-pump for delivering insulin or other drugs | |
AU2537997A (en) | Catheter apparatus with means for subcutaneous delivery of anesthetic agent or other fluid medicament | |
AU2537897A (en) | Catheter apparatus with means for subcutaneous delivery of anesthetic agent or other fluid medicament | |
EP0399765A3 (en) | System for transdermal drug delivery | |
NZ236002A (en) | Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole | |
DK0458829T3 (es) | ||
PT1042339E (pt) | Hidratos de carbono uteis para sistemas de distribuicao em fase solida | |
ES2195408T3 (es) | Microparticulas perforadas y procedimientos de uso. | |
DE3879853T2 (de) | Klebstoffzusammensetzung, Zusammensetzung mit kontrollierter Wirkstofffreisetzung und System zur transdermalen Anwendung von Arzneien. | |
AU693073B2 (en) | Systems and methods for communicating with ambulatory medical devices such as drug delivery devices | |
AU4045993A (en) | Transdermal drug delivery system | |
DK0686053T3 (da) | Apparat til injektion af et farmaceutisk præparat i fast form | |
ATE233545T1 (de) | Vorrichtung für ionophoretischen verabreichung mit polymerschaumbehältern | |
PL315127A1 (en) | Deuterised biologically active substances for percutaneous administration | |
EP0416575A3 (en) | Drug delivery compositions based on biological materials and methods for preparing such compositions | |
GR3035132T3 (en) | Implantable device for administering active substances to plants | |
ATE295157T1 (de) | Mittel zur transdermalen verabreichung von arzneistoffen | |
GB2245831B (en) | Drug delivery system for administering growth factors | |
DE69702557D1 (de) | Brennstoffzufuhrsystem zur Dekontamination der Einspritzdosierungsrate | |
ES2170776T3 (es) | Sistema de administracion de vacuna. | |
Zittoun et al. | Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group | |
ZA9711270B (en) | Precursory forms and new analogues of camptothecin, the processes for their preparation, their medical application and the pharmaceutical substances that contain them. |